News | Medicines Discovery Catapult

We can arrange media interviews and tours of our laboratory and facilities. Spokespeople, including our CEO, Chris Molloy, are available to comment on our unique approach to supporting SMEs and the discovery of new medicines.

We can also provide expert opinion and analysis on the UK government’s Industrial Strategy, the role of the NHS, SMEs, pharma and the importance of patient data in drug discovery. You can find out more about our work in the State of the Discovery Nation report.

For more information please email media@md.catapult.org.uk.

Signup to our media list to be kept up-to-date with our work and commentary and opinion on key news stories.

Medicines Discovery Catapult awarded funding to establish Cheshire & Warrington as an international powerhouse for the creation of new medicines

Today (11th August 2020), Medicines Discovery Catapult (MDC) announce that it has been awarded government seedcorn funding; provided through UK Research and Innovation’s flagship £236m Strength in Places Fund, along with project partner Cheshire & Warrington Local Enterprise Partnership (LEP). The funding will be used to create a regional consortium and develop the full stage […]

Cheshire East Council welcomes funding for Validation Centre of Excellence at Alderley Park

Cheshire East Council has welcomed the announcement on 4 August 2020, of £15.5 million of the Getting Building Fund for investment in schemes in Cheshire and Warrington, one of which is a new Validation Centre of Excellence at Alderley Park. The Council has worked with Cheshire and Warrington Local Enterprise Partnership (C+W LEP) to identify […]

Alderley Park Lighthouse Laboratory processes 1 million samples

The Alderley Park Lighthouse Lab, which was launched to rapidly expand COVID-19 testing capacity, has processed more than 1 million test samples since opening. The Alderley Park Lighthouse Lab is hosted by Medicines Discovery Catapult at Bruntwood SciTech’s Alderley Park in Cheshire and officially began testing in April. Professor Sir John Bell GBE FRS, UK […]

What makes a drug discovery consortium successful? Our scientists discuss in Nature Reviews Drug Discovery

Consortia are enabling drug discovery in areas that individual organizations are unable to support alone because of the high risk or the need to pool information. MDC’s Peter Simpson (Chief Scientific Officer) and Graeme Wilkinson (Head of Virtual R&D) discuss the desirable features that can underpin the success of such consortia for Nature Reviews Drug […]

Psychiatry Consortium launches second call for proposals

The Psychiatry Consortium is again seeking project proposals which focus on the validation of novel molecular drug-targets for the following mental health conditions: psychotic disorders, bipolar disorder, depression, anxiety, stress-related disorders, PTSD, OCD, autism spectrum disorders as well as psychiatric symptoms associated with dementia and other cognitive disorders The Psychiatry Consortium intend to fund projects […]

Medicines Discovery Catapult welcomes new Board Members

This week the Medicines Discovery Catapult has welcomed three new Board Members. Alistair Macdonald, Graham Clarke and Sue Wallcraft have joined the Medicines Discovery Catapult Board as Non-executive Directors. Find out more about the Medicines Discovery Catapult Board here. Alistair Macdonald Graham Clarke Sue Wallcraft

Supporting the race for treatments new collaboration launched to drive understanding of COVID-19

Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19 Today (27th April) Medicines Discovery Catapult, Retrogenix and Peak Proteins announce a collaboration to advance understanding of the cellular mechanisms of infection by COVID-19. This collaboration aims to combine excellence in drug discovery and protein science with innovative cellular microarray technology […]

Britain’s biggest network of diagnostic labs are completed in 5 weeks

Sites in Milton Keynes, Glasgow and Alderley Park in Cheshire are now live and are already testing thousands of patient samples for coronavirus (COVID-19) each day. The rapid creation of 3 new Lighthouse Labs in Milton Keynes, Glasgow and Alderley Park in Cheshire is increasing the country’s capacity to test for coronavirus, with each site […]

Testing capacity increases as second Lighthouse Lab becomes fully operational

The second mega-lab at Alderley Park in Cheshire has begun to test thousands of patient samples a day for coronavirus. The lab is part of what will be the biggest network of diagnostic testing facilities in British history, testing samples from drive-through test sites across the country Testing Minister Lord Bethell has today personally thanked […]

Older posts

Newer posts